Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

FEXOFENADINE HYDROCHLORIDE HIVES Drug Profile

« Back to Dashboard

Which patents cover Fexofenadine Hydrochloride Hives, and what generic Fexofenadine Hydrochloride Hives alternatives are available?

Fexofenadine Hydrochloride Hives is a drug marketed by Dr Reddys Labs Ltd, Sciegen Pharms Inc, Wockhardt Ltd, Teva, Sun Pharm Inds, and Mylan. and is included in six NDAs.

The generic ingredient in FEXOFENADINE HYDROCHLORIDE HIVES is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and four suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.

Summary for Tradename: FEXOFENADINE HYDROCHLORIDE HIVES

Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list85
Clinical Trials: see list1,014
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FEXOFENADINE HYDROCHLORIDE HIVES at DailyMed

Pharmacology for Tradename: FEXOFENADINE HYDROCHLORIDE HIVES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
FEXOFENADINE HYDROCHLORIDE HIVES
fexofenadine hydrochloride
TABLET;ORAL076502-007Apr 12, 2011OTCNoNo► Subscribe► Subscribe
Teva
FEXOFENADINE HYDROCHLORIDE HIVES
fexofenadine hydrochloride
TABLET;ORAL076447-007Apr 13, 2011OTCNoNo► Subscribe► Subscribe
Sciegen Pharms Inc
FEXOFENADINE HYDROCHLORIDE HIVES
fexofenadine hydrochloride
TABLET;ORAL204507-005Sep 16, 2015OTCNoNo► Subscribe► Subscribe
Mylan
FEXOFENADINE HYDROCHLORIDE HIVES
fexofenadine hydrochloride
TABLET;ORAL077081-009Jul 21, 2011OTCNoNo► Subscribe► Subscribe
Teva
FEXOFENADINE HYDROCHLORIDE HIVES
fexofenadine hydrochloride
TABLET;ORAL076447-009Apr 13, 2011OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot